A Backstage View Of Roche’s Recent Collaborations

Deal-Making Activities Continue In Full Force Amid Coronavirus Chaos

In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.

Silhouettes_Curtain
Behind the scenes at Roche Pharma Partnering

More from Strategy

More from Business